Status:
UNKNOWN
Survival Outcomes of Uterine Cervical Malignancies in Chinese Population
Lead Sponsor:
Lei Li
Conditions:
Uterine Cervical Neoplasms
Survival
Eligibility:
FEMALE
Brief Summary
This study aims to determine survival outcomes (overall survival and progression-free survival) of primary malignancies of uterine cervix in China and relevant risk factors in a prospective cohort stu...
Eligibility Criteria
Inclusion
- Primary malignancies of uterine cervix.
Exclusion
- Secondary malignancies of uternie cervix.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03291236
Start Date
January 1 2017
End Date
January 1 2023
Last Update
February 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Li
Beijing, China/Beiing, China, 100000